SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-16-015293
Filing Date
2016-05-03
Accepted
2016-05-02 18:10:08
Documents
47
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rgls20160331-10q.htm 10-Q 776519
2 EXHIBIT 10.3 ex-10320160331.htm EX-10.3 1950
3 EXHIBIT 31.1 ex-31120160331.htm EX-31.1 12056
4 EXHIBIT 31.2 ex-312x20160331.htm EX-31.2 12052
5 EXHIBIT 32.1 ex-321x20160331.htm EX-32.1 11327
  Complete submission text file 0001628280-16-015293.txt   3470899

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rgls-20160331.xml EX-101.INS 628055
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgls-20160331.xsd EX-101.SCH 27106
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgls-20160331_cal.xml EX-101.CAL 46707
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgls-20160331_def.xml EX-101.DEF 108175
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgls-20160331_lab.xml EX-101.LAB 369943
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgls-20160331_pre.xml EX-101.PRE 202343
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 161613098
SIC: 2834 Pharmaceutical Preparations